• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hespintor对PI3K/Akt通路的负调控诱导肝癌细胞周期停滞。

Hespintor Negative Regulation of PI3K/Akt Pathway Induces Cell Cycle Arrest of Hepatocellular Carcinoma.

作者信息

Sun J, Lun Y Z, Liu B, Dong W

机构信息

Key Laboratory of Screening and Control of Infectious Diseases, Fujian Provincial University, Quanzhou Medical College, Quanzhou, China.

Department of Laboratory Medicine, Putian University, Putian, China.

出版信息

Bull Exp Biol Med. 2024 Dec;178(2):237-243. doi: 10.1007/s10517-025-06314-0. Epub 2025 Jan 7.

DOI:10.1007/s10517-025-06314-0
PMID:39762705
Abstract

The mechanism of Hespintor (a protein of serpin family) inhibitory action on the growth of inoculated hepatocellular carcinoma was studied in a model of human hepatoma in nude mice by using on long-noncoding RNA (lncRNA) sequencing. Two days after tumor transplantation, Hespintor or normal saline was injected into the caudal vein at a dose of 15 μg/kg (2 times a week over 4 weeks). The tumors were isolated in 4 weeks after subcutaneous injection of human hepatoma MHCC97-H cells. In Hespintor and control groups, the complementary DNA libraries of tumor tissues were established, and transcriptome sequencing was performed. Based on RNA-sequencing data, the differentially expressing lncRNA genes (DEGs lncRNA) were obtained, and functional enrichment and interaction analyses were performed to find the regulatory gene sets. Then, the network module division method was employed to identify the key genes of the Hespintor action, as well as to build the regulatory network and critical pathways associated with the key genes with validation of the results by Western blotting. The target gene sets regulated by DEGs lncRNA were mainly enriched in cell behavior, transcriptional regulation, and cell cycle. The PI3K/Akt signaling pathway related to the revealed gene sets plays a leading role in the antitumor action of Hespintor, targeted by this serpin to down-regulate expression levels of the cell cycle regulatory proteins Cyclin D1, P-Rb, CDK4, and CDK6, thereby arresting the cell cycle in G1/S phase.

摘要

通过长链非编码RNA(lncRNA)测序,在裸鼠人肝癌模型中研究了丝氨酸蛋白酶抑制剂家族蛋白Hespintor对接种的肝细胞癌生长的抑制作用机制。肿瘤移植两天后,以15μg/kg的剂量经尾静脉注射Hespintor或生理盐水(每周2次,共4周)。皮下注射人肝癌MHCC97-H细胞4周后分离肿瘤。在Hespintor组和对照组中,建立肿瘤组织的互补DNA文库并进行转录组测序。基于RNA测序数据,获得差异表达的lncRNA基因(DEGs lncRNA),并进行功能富集和相互作用分析以找到调控基因集。然后,采用网络模块划分方法鉴定Hespintor作用的关键基因,构建与关键基因相关的调控网络和关键途径,并通过蛋白质印迹法验证结果。DEGs lncRNA调控的靶基因集主要富集于细胞行为、转录调控和细胞周期。与所揭示的基因集相关的PI3K/Akt信号通路在Hespintor的抗肿瘤作用中起主导作用,这种丝氨酸蛋白酶抑制剂靶向该通路以下调细胞周期调节蛋白Cyclin D1、P-Rb、CDK4和CDK6的表达水平,从而使细胞周期停滞在G1/S期。

相似文献

1
Hespintor Negative Regulation of PI3K/Akt Pathway Induces Cell Cycle Arrest of Hepatocellular Carcinoma.Hespintor对PI3K/Akt通路的负调控诱导肝癌细胞周期停滞。
Bull Exp Biol Med. 2024 Dec;178(2):237-243. doi: 10.1007/s10517-025-06314-0. Epub 2025 Jan 7.
2
Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.下调的长链非编码 RNA TP73-AS1 通过 PTEN/Akt 信号通路降低肝癌的放射抵抗性。
Cell Cycle. 2019 Nov;18(22):3177-3188. doi: 10.1080/15384101.2019.1671089. Epub 2019 Sep 29.
3
LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway.长链非编码 RNA ZFAS1 通过 PI3K/AKT 信号通路调控 ATIC 转录,促进肝癌的增殖和迁移。
J Cancer Res Clin Oncol. 2024 Jul 13;150(7):351. doi: 10.1007/s00432-024-05877-1.
4
ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.ERCC6L 通过激活 PI3K/AKT 和 NF-κB 信号通路促进肝癌的进展。
BMC Cancer. 2020 Sep 5;20(1):853. doi: 10.1186/s12885-020-07367-2.
5
Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.罗哌卡因通过抑制 IGF-1R/PI3K/AKT/mTOR 信号轴抑制人肝癌细胞的肿瘤生物学特性。
Bioengineered. 2021 Dec;12(2):9162-9173. doi: 10.1080/21655979.2021.1995103.
6
Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.长链非编码RNA LEF1-AS1作为微小RNA-10a-5p的调节因子,通过激活AKT信号通路增强MSI1表达并促进肝癌细胞的化学抗性。
J Cell Biochem. 2021 Jan;122(1):86-99. doi: 10.1002/jcb.29833. Epub 2020 Aug 12.
7
microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.miRNA-1914 受 lncRNA DUXAP10 调控,通过靶向 GPR39 介导的 PI3K/AKT/mTOR 通路抑制 HCC 细胞增殖。
J Cell Mol Med. 2019 Dec;23(12):8292-8304. doi: 10.1111/jcmm.14705. Epub 2019 Oct 1.
8
LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1.长链非编码 RNA TTN-AS1 通过海绵吸附 miR-16-5p 和上调细胞周期蛋白 E1 加剧肝癌对索拉非尼的耐药性。
Biomed Pharmacother. 2021 Jan;133:111030. doi: 10.1016/j.biopha.2020.111030. Epub 2020 Nov 28.
9
EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.EVA1A 通过调节 PI3K/AKT/p53 信号轴逆转肝癌对乐伐替尼的耐药性。
Apoptosis. 2024 Aug;29(7-8):1161-1184. doi: 10.1007/s10495-024-01967-0. Epub 2024 May 14.
10
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.谷氨酰胺酶2负向调节PI3K/AKT信号通路,并在人肝细胞癌中显示出肿瘤抑制活性。
Oncotarget. 2014 May 15;5(9):2635-47. doi: 10.18632/oncotarget.1862.

本文引用的文献

1
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.尿激酶型纤溶酶原激活物受体(uPAR)作为癌症的治疗靶点。
J Transl Med. 2022 Mar 18;20(1):135. doi: 10.1186/s12967-022-03329-3.
2
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.心血管疾病中靶向纤溶酶原激活物抑制剂-1:纤溶酶原激活物抑制剂-1功能及抑制作用的结构见解
Front Cardiovasc Med. 2020 Dec 22;7:622473. doi: 10.3389/fcvm.2020.622473. eCollection 2020.
3
The Inhibitory Effects of Recombinant Hespintor Combined with Sorafenib on Transplanted Human Hepatoma in Nude Mice, and Transcriptional Regulation of Hespintor Based on RNA-Seq.
重组Hespintor联合索拉非尼对裸鼠人肝癌移植瘤的抑制作用及基于RNA测序的Hespintor转录调控
J Cancer. 2021 Jan 1;12(2):343-357. doi: 10.7150/jca.50500. eCollection 2021.
4
Gypenoside Inhibits Endothelial Cell Apoptosis in Atherosclerosis by Modulating Mitochondria through PI3K/Akt/Bad Pathway.绞股蓝总苷通过调节 PI3K/Akt/Bad 通路抑制动脉粥样硬化内皮细胞凋亡。
Biomed Res Int. 2020 Jun 20;2020:2819658. doi: 10.1155/2020/2819658. eCollection 2020.
5
Long Non-Coding RNA in the Pathogenesis of Cancers.长链非编码 RNA 在癌症发病机制中的作用。
Cells. 2019 Sep 1;8(9):1015. doi: 10.3390/cells8091015.
6
The Role of PEDF in Pancreatic Cancer.PEDF 在胰腺癌中的作用。
Anticancer Res. 2019 Jul;39(7):3311-3315. doi: 10.21873/anticanres.13473.
7
Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo.新型尿激酶型纤溶酶原激活物抑制剂 SPINK13 抑制体内肝细胞癌的生长和转移。
Pharmacol Res. 2019 May;143:73-85. doi: 10.1016/j.phrs.2019.03.009. Epub 2019 Mar 9.
8
Serpins: Development for Therapeutic Applications.丝氨酸蛋白酶抑制剂:治疗应用的进展
Methods Mol Biol. 2018;1826:255-265. doi: 10.1007/978-1-4939-8645-3_17.
9
Overview of Serpins and Their Roles in Biological Systems.丝氨酸蛋白酶抑制剂及其在生物系统中的作用概述。
Methods Mol Biol. 2018;1826:1-7. doi: 10.1007/978-1-4939-8645-3_1.
10
Urokinase Type Plasminogen Activator and the Molecular Mechanisms of its Regulation in Cancer.尿激酶型纤溶酶原激活剂及其在癌症中的调控分子机制
Protein Pept Lett. 2017;24(10):936-946. doi: 10.2174/0929866524666170818161132.